Income-related disparities in kidney transplant graft failures are eliminated by medicare's immunosuppression coverage

American Journal of Transplantation

Volumn 8, Issue 12, 2008, Pages 2636-2646

  Woodward, R S ^a,e   Page, T F ^b   Soares, R ^b   Schnitzler, M A ^c   Lentine, K L ^c   Brennan, D C ^d  

^a UNIVERSITY OF NEW HAMPSHIRE   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunosuppression; Insurance; Kidney graft survival; Medicare; Outcomes

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH INSURANCE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL;

ADULT; AGED; COHORT STUDIES; FEMALE; GRAFT REJECTION; HEALTHCARE DISPARITIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCOME; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MEDICARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); REGRESSION ANALYSIS; UNITED STATES;

EID: 55949099302     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02422.x     Document Type: Article

References (13)

1. Rettig RA. Implementing the End-Stage Renal Disease Program of Medicare. Santa Monica, CA : Rand Report R-2505-HCFA/HEW 1980. Available from : http://www.rand.org/pubs/reports/2005/R2505.pdf. Accessed August 16, 2006.
2. Evans RW, Manninen DL, Garrison LP Jr. et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985 312 : 553 559.
3. Eggers PW. Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 1988 318 : 223 229.
4. Kasiske BL, Cohen D, Lucey MR, Neylan JF. Payment for immunosuppression after organ transplantation. American Society of Transplantation. JAMA 2000 283 : 2445 2450.
5. Woodward RS, Schnitzler MA, Lowell JA, Spitznagel EL, Brennan DC. Effect of extended coverage of immunosuppressive medications by Medicare on the survival of cadaveric renal transplants. Am J Transplant 2001 1 : 69 73.
6. United States Census Bureau. Census 2000 Summary File 3. Available from : http://www.factfinder.census.gov. Accessed September 27, 2006.
7. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000 342 : 605 612.
8. Kalil RS, Heim-Duthoy KL, Kasiske BL. Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 1992 20 : 63 69.
9. Press R, Carrasquillo O, Nickolas T, Radhakrishnan J, Shea S, Barr RG. Race/ethnicity, poverty status, and renal transplant outcomes. Transplantation 2005 80 : 917 924.
10. Chakkera HA, O'Hare AM, Johansen KL et al. Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. J Am Soc Nephrol 2005 16 : 269 277.
11. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005 16 : 496 506.
12. Lentine KL, Schnitzler MA, Abbott KC et al. De novo congestive heart failure after kidney transplantation: A common condition with poor prognostic implications. Am J Kidney Dis 2005 46 : 720 733.
13. Rao PS, Schaubel DE, Jia X, Li S, Port FK, Saran R. Survival on dialysis post-kidney transplant failure: Results from the Scientific Registry of Transplant Recipients. Am J Kidney Dis 2007 49 : 294 300.